Optimizing the Care of Patients With Progressive-Fibrosing Interstitial Lung Disease: Applying the Latest Data
The intended audience for this series is pulmonologists, internists, rheumatologists and other health care professionals involved in the management of patients with progressive fibrosing interstitial lung disease (PF-ILD).